NDC 80425-0303-01 - Buspirone Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0303
- Requested NDC
- 80425-0303-01
- Package NDCs from labels
- 80425-0303-1, 80425-0303-2, 80425-0303-3, 80425-0303-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Buspirone Hydrochloride - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0303-1 | Buspirone Hydrochloride | 30 in 1 BOTTLE | TABLET | 30 | 2 | |
| 80425-0303-2 | Buspirone Hydrochloride | 60 in 1 BOTTLE | TABLET | 60 | 2 | |
| 80425-0303-3 | Buspirone Hydrochloride | 90 in 1 BOTTLE | TABLET | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0303 | BUSPIRONE HYDROCHLORIDE TABLET [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 2 | Current NDC, 3 package rows | 20250102_f8afd9b8-0885-2f0c-e053-6294a90a9c57.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0303-1 | EA - Each | 80425-0303 | f4913649-e1ba-42f9-8427-a607b54d7ddf | 1 | 2023-06-06 |
| 80425-0303-2 | EA - Each | 80425-0303 | 37cb4f00-cf48-48e7-87f2-e17af97a0001 | 1 | 2023-06-06 |
| 80425-0303-3 | EA - Each | 80425-0303 | 9453aa87-69d6-4b8b-9098-5a9978f87ac7 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | REMEDYREPACK INC. | fa4d5cac-f687-4440-99d2-8bb27cf2f4ed | 2026-09-04 | Warnings, Adverse reactions | 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Cardinal Health 107, LLC | ef90af23-d97e-4094-971b-1d8114218b10 | 2026-09-02 | Warnings, Adverse reactions | 866083 866094 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | REMEDYREPACK INC. | ed2b56fe-e02f-46bc-808a-352f9bbb5b57 | 2026-08-27 | Warnings, Adverse reactions | ANDA210907 866090 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Major Pharmaceuticals | 8dc1ee33-e5aa-4462-8fb9-9bbdf5463488 | 2026-08-05 | Warnings, Adverse reactions | 866083 866094 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Proficient Rx LP | 801803eb-be17-4064-8813-7ccf52316cde | 2026-08-01 | Warnings, Adverse reactions | ANDA210907 866083 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | REMEDYREPACK INC. | 3155e607-bc7f-4e90-9edf-8e862dd5737d | 2026-07-31 | Warnings, Adverse reactions | 866018 207LT9J9OC |
| Buspirone hydrochloride | BUSPIRONE HYDROCHLORIDE | AiPing Pharmaceutical, Inc. | 55810b17-4796-49d0-90e4-8e075d62eda4 | 2026-07-29 | Warnings, Adverse reactions | 866083 866090 866094 866018 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Cardinal Health 107, LLC | 2acc7da1-d5b8-4404-a3c6-d51ed82cc4fd | 2026-07-29 | Warnings, Adverse reactions | 866083 866094 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | REMEDYREPACK INC. | fd05160d-24c6-4371-8b2c-c0f78c8b468e | 2026-07-28 | Warnings, Adverse reactions | 866018 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Golden State Medical Supply, Inc. | bcce49d3-c8eb-9f9b-e053-2995a90a67d9 | 2026-07-27 | Warnings, Adverse reactions | 866083 866090 866094 866018 207LT9J9OC |
| Buspirone hydrochloride | BUSPIRONE HYDROCHLORIDE | A-S Medication Solutions | 7b222cb0-0061-4a3e-9d0f-e9f120e7f5d9 | 2026-07-24 | Warnings, Adverse reactions | 866094 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Redpharm Drug | 5718bc19-07b2-b61d-e063-6394a90a6e80 | 2026-07-21 | Warnings, Adverse reactions | 866083 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | REMEDYREPACK INC. | a9fc7091-b3ce-45fd-8d89-aeebdd81c327 | 2026-07-16 | Warnings, Adverse reactions | 866083 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Strides Pharma Inc. | cb0091ad-97f6-431b-b2b9-e03171eed274 | 2026-07-08 | Warnings, Adverse reactions | 866083 866090 866094 866018 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | REMEDYREPACK INC. | b42cc365-6259-4d2e-9648-d37718b65e1e | 2026-06-30 | Warnings, Adverse reactions | 866094 207LT9J9OC |
| Buspirone hydrochloride | BUSPIRONE HYDROCHLORIDE | Major Pharmaceuticals | a9bb9216-3dac-4e8a-9df9-f72c2eaef160 | 2026-06-30 | Warnings, Adverse reactions | 866018 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | IPG Pharmaceuticals, Inc | 2c516eec-65d9-4481-8823-ae6b6da84062 | 2026-06-21 | Warnings, Adverse reactions | 207LT9J9OC |
| busPIRone HCl | BUSPIRONE HYDROCHLORIDE | Northwind Health Company, LLC | 472049d2-c4d9-5a38-e063-6294a90a5cf1 | 2026-06-19 | Warnings, Adverse reactions | 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Northwind Health Company, LLC | 1d883a13-4877-c6c7-e063-6294a90a5137 | 2026-06-19 | Warnings, Adverse reactions | 866083 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Unit Dose Solutions, Inc. | 544a4570-bd7f-72bb-e063-6394a90ab8d6 | 2026-06-15 | Warnings, Adverse reactions | ANDA210907 866083 866094 207LT9J9OC |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.